M
Marc-Henri Stern
Researcher at Curie Institute
Publications - 196
Citations - 12240
Marc-Henri Stern is an academic researcher from Curie Institute. The author has contributed to research in topics: Gene & Breast cancer. The author has an hindex of 49, co-authored 168 publications receiving 9402 citations. Previous affiliations of Marc-Henri Stern include Necker-Enfants Malades Hospital & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.
Lenha Mobuchon,Aude Battistella,Claire Bardel,Ghislaine Scelo,Alexia Renoud,Alexandre Houy,Nathalie Cassoux,Maud Milder,Geraldine Cancel-Tassin,Olivier Cussenot,Olivier Delattre,Céline Besse,Anne Boland,Jean-François Deleuze,David G. Cox,Marc-Henri Stern +15 more
TL;DR: expression analyses showed that the CLPTM1L gene contained in this region was more expressed in people with the risk variants, pointing to CLPTL1L playing a role in tumor development.
Journal ArticleDOI
The TCL1A oncoprotein interacts directly with the NF-κB inhibitor IκB
Virginie Ropars,Virginie Ropars,Gilles Despouy,Gilles Despouy,Marc-Henri Stern,Marc-Henri Stern,Serge Benichou,Serge Benichou,Christian Roumestand,Christian Roumestand,Stefan T. Arold,Stefan T. Arold +11 more
TL;DR: By interfering with the inhibition of NF-κB by IκB, TCL1A may increase the concentration of free NF-σB molecules sufficiently to trigger expression of anti-apoptotic genes, suggesting an additional route by which T CL1A might cause cancer.
Journal ArticleDOI
Erratum: Upcoming translational challenges for uveal melanoma
Nabil Amirouchene-Angelozzi,Marie Schoumacher,Marc-Henri Stern,Nathalie Cassoux,Laurence Desjardins,Sophie Piperno-Neumann,Olivier Lantz,Sergio Roman-Roman +7 more
TL;DR: An error in the formatting of the authors' names was identified, and first names and surnames had been inverted.
Journal ArticleDOI
ART-DeCo: easy tool for detection and characterization of cross-contamination of DNA samples in diagnostic next-generation sequencing analysis
Alice Fiévet,Alice Fiévet,Virginie Bernard,Henrique Tenreiro,Catherine Dehainault,Elodie Girard,Vivien Deshaies,Philippe Hupé,Olivier Delattre,Olivier Delattre,Marc-Henri Stern,Marc-Henri Stern,Dominique Stoppa-Lyonnet,Dominique Stoppa-Lyonnet,Dominique Stoppa-Lyonnet,Lisa Golmard,Claude Houdayer +16 more
TL;DR: ART-DeCo, a tool using the allelic ratio (AR) of the Single Nucleotide Polymorphisms sequenced with regions of interest, which can be implemented in any NGS workflow, from gene panel to genome-wide analyses, is developed.
Journal ArticleDOI
Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas.
Nicolas Pécuchet,Nicolas Pécuchet,Tatiana Popova,Tatiana Popova,Elodie Manié,Elodie Manié,Carlo Lucchesi,Carlo Lucchesi,Aude Battistella,Aude Battistella,Anne Vincent-Salomon,Anne Vincent-Salomon,Virginie Caux-Moncoutier,Marc A. Bollet,Brigitte Sigal-Zafrani,Xavier Sastre-Garau,Dominique Stoppa-Lyonnet,Marc-Henri Stern,Marc-Henri Stern +18 more
TL;DR: The simplified BRCA2 classifier based on the co‐occurrence of LOH at 13q13 and 14q32 could provide an indication to test for BRCa2 mutation in patients with ER‐positive IDC.